Clary, Douglas O. External Author

Publications

Sort by

Selected publications

  • Phase i study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumorsInvestigational New Drugs2015 Academic Article GET IT
    Times cited: 11